Glucosamine & Arthritis - list of available clinical trials for arthritis drug - Brief Article

Nutrition Action Healthletter, July, 2001

In May, we said that a new National Institutes of Health (NIH) study called GAIT (Glucosamine/Chondroitin Arthritis Intervention Trial) would use the Cosamin brand ("Quick Studies,' page 9). Not so. The study will use the same glucosamine and chondroitin formulations that are found in Cosamin, the only U.S. brand that contains them. We also printed an incorrect phone number for readers who want to volunteer for the study.

If you're interested in volunteering, you need to: (1) be 40 or older, (2) have been diagnosed with osteoarthritis of the knee, (3) not have any other arthritis-like disease (like gout), (4) not have diabetes, (5) be willing to stop taking glucosamine or chondroitin (if you're currently taking either or both), (6) be willing to take a COX-2 inhibitor drug (like Celebrex or Vioxx), and (7) be willing to travel to one of the centers where the study will take place. The best way to contact the study is by e-mailing the center nearest you. If you can't e-mail, leave a message at (801) 587-9627 (it's in Utah).

ALABAMA
University of Alabama, Birmingham
tina.parkhill@ccc.uab.edu

CALIFORNIA
Cedars-Sinai Medical Center, Beverly Hills
guiglianoa@cshs.org
University of California, San Francisco
rthiess@itsa.ucsf.edu

INDIANA
Indiana University, Indianapolis
hcountry@iupui.edu

KANSAS
Arthritis Research Center Foundation, Wichita
kathyu@arthritis-research.org

NEBRASKA
University of Nebraska Medical Center,
Omaha
dogrady@unmc.edu

NEW YORK
Hospital for Joint Diseases, New York City
vivian.abellana@med.nyu.edu

OHIO
Case Western Reserve University, Beechwood
lernans71@aol.com

PENNSYLVANIA
Hospital of the University of Pennsylvania,
Philadelphia
ms_sieck@hotmail.com
University of Pittsburgh
pauli@msx.dept-med.pitt.edu

TEXAS
Presbyterian Hospital of Dallas
emmabarnboym@texashealth.org

UTAH
University of Utah, Salt Lake City
alisa.kim@hsc.utah.edu

WASHINGTON
Virginia Mason Research Center, Seattle

crgesv@vmrnc.org